Roche has named James (Jim) Cassidy, M.D., Ph.D., head of translational medicine in the oncology discovery and translational area (DTA) in pharma research and early development (pRED).
A British native, Jim was Professor of Oncology, head of the Department of Cancer Research and head of the Division of Cancer Sciences and Molecular Pathology at the University of Glasgow, Scotland. His major research interests include Telomerase, DNA repair, drug resistance and molecular pharmacology of anti-cancer drugs.
Previously, he was the first Professor of Oncology at Aberdeen University in the U.K., where he developed both an academic unit of clinical oncology and a laboratory-based cancer research group.
Jim chairs the West of Scotland Cancer Research Network and is a member of Cancer Research U.K., the American Society of Clinical Oncology, the American and British Associations for Cancer Research, the Association of Cancer Physicians and the National Cancer Research Institute. He is also a Fellow of the Royal Society of Edinburgh.